BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crossnohere NL, Janse S, Janssen E, Bridges JFP. Comparing the Preferences of Patients and the General Public for Treatment Outcomes in Type 2 Diabetes Mellitus. Patient 2021;14:89-100. [PMID: 32885395 DOI: 10.1007/s40271-020-00450-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Howell M, Amir N, Guha C, Manera K, Tong A. The critical role of mixed methods research in developing valid and reliable patient-reported outcome measures. Methods 2022;205:213-9. [PMID: 35878750 DOI: 10.1016/j.ymeth.2022.07.012] [Reference Citation Analysis]
2 Liu S, Liu J, Yu Y, Si L, Tang C, Liu Z, Chen Y. What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in China. Front Pharmacol 2021;12:802897. [PMID: 35002736 DOI: 10.3389/fphar.2021.802897] [Reference Citation Analysis]
3 Tsai JH, Crossnohere NL, Strong T, Bridges JFP. Measuring Meaningful Benefit-Risk Tradeoffs to Promote Patient-Focused Drug Development in Prader-Willi Syndrome: A Discrete-Choice Experiment. MDM Policy Pract 2021;6:23814683211039457. [PMID: 34497876 DOI: 10.1177/23814683211039457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]